PART 01: EXECUTIVE SUMMARY 11 PART 02: SCOPE OF THE REPORT 22 2.1 Preface 23 2.2 Preface 24 2.3 Currency conversion rates for US$ 26 PART 03: MARKET LANDSCAPE 27 Market ecosystem 28 Market characteristics 33 Market segmentation analysis 35 Value chain analysis 36 PART 04: MARKET SIZING 37 Market definition 38 Market sizing 2019 41 Market size and forecast 2019-2024 43 Market outlook 45 PART 05: FIVE FORCES ANALYSIS 46 Bargaining power of buyers 49 Bargaining power of suppliers 50 Threat of new entrants 51 Threat of substitutes 52 Threat of rivalry 53 Market condition 54 PART 06: MARKET SEGMENTATION BY END-USER 55 Market segmentation by end-user 56 Comparison by end-user 57 Pharmaceutical companies - Market size and forecast 2019-2024 58 Other organizations - Market size and forecast 2019-2024 60 Market opportunity by end-user 62 PART 07: CUSTOMER LANDSCAPE 63 PART 08: GEOGRAPHIC LANDSCAPE 66 Geographic segmentation 67 Geographic comparison 68 North America - Market size and forecast 2019-2024 70 Europe - Market size and forecast 2019-2024 72 Asia - Market size and forecast 2019-2024 74 ROW - Market size and forecast 2019-2024 76 Key leading countries 78 Market opportunity 79 PART 09: DECISION FRAMEWORK 80 PART 10: DRIVERS AND CHALLENGES 82 Market drivers 83 Market challenges 86 PART 11: MARKET TRENDS 90 Advent of AI in clinical research 91 Increasing outsourcing activities to CROs 92 Increasing adoption of cloud technologies in pharmaceutical production and testing 93 PART 12: VENDOR LANDSCAPE 94 Overview 95 Landscape disruption 96 Competitive scenario 99 PART 13: VENDOR ANALYSIS 100 Vendors covered 101 Vendor classification 103 Market positioning of vendors 104 Bilcare Ltd. 105 Caligor Coghlan Pharma Services 107 Corden Pharma International GmbH 110 Mawdsley-Brooks & Co. Ltd. 113 PCI Pharma Services 117 Piramal Enterprises Ltd. 120 Sentry BioPharma Services 123 Sharp 126 The WestRock group 130 Thermo Fisher Scientific Inc. 133 PART 14: APPENDIX 139 Research methodology 140 List of abbreviations 143 Definition of market positioning of vendors 145 PART 15: EXPLORE TECHNAVIO 146   Exhibit 01: Vendors: Key offerings 25 Exhibit 02: Global healthcare market 31 Exhibit 03: Segments of global healthcare market 32 Exhibit 04: Market characteristics 33 Exhibit 05: Market segments 35 Exhibit 06: Market definition - Inclusions and exclusions checklist 40 Exhibit 07: Market size 2019 42 Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions) 43 Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) 44 Exhibit 10: Five forces analysis 2019 47 Exhibit 11: Five forces analysis 2024 48 Exhibit 12: Bargaining power of buyers 49 Exhibit 13: Bargaining power of suppliers 50 Exhibit 14: Threat of new entrants 51 Exhibit 15: Threat of substitutes 52 Exhibit 16: Threat of rivalry 53 Exhibit 17: Market condition - Five forces 2019 54 Exhibit 18: End-user - Market share 2019-2024 (%) 56 Exhibit 19: Comparison by end-user 57 Exhibit 20: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions) 58 Exhibit 21: Pharmaceutical companies - Year-over-year growth 2020-2024 (%) 59 Exhibit 22: Other organizations - Market size and forecast 2019-2024 ($ millions) 60 Exhibit 23: Other organizations - Year-over-year growth 2020-2024 (%) 61 Exhibit 24: Market opportunity by end-user 62 Exhibit 25: Customer landscape 64 Exhibit 26: Market share by geography 2019-2024 (%) 67 Exhibit 27: Geographic comparison 69 Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions) 70 Exhibit 29: North America - Year-over-year growth 2020-2024 (%) 71 Exhibit 30: Top 3 countries in North America 71 Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions) 72 Exhibit 32: Europe - Year-over-year growth 2020-2024 (%) 73 Exhibit 33: Top 3 countries in Europe 73 Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions) 74 Exhibit 35: Asia - Year-over-year growth 2020-2024 (%) 75 Exhibit 36: Top 3 countries in Asia 75 Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions) 76 Exhibit 38: ROW - Year-over-year growth 2020-2024 (%) 77 Exhibit 39: Top 3 countries in ROW 77 Exhibit 40: Key leading countries 78 Exhibit 41: Market opportunity 79 Exhibit 42: Impact of drivers and challenges 89 Exhibit 43: Vendor landscape 95 Exhibit 44: Landscape disruption 96 Exhibit 45: Vendors covered 101 Exhibit 46: Vendor classification 103 Exhibit 47: Market positioning of vendors 104 Exhibit 48: Bilcare Ltd. - Vendor overview 105 Exhibit 49: Bilcare Ltd. - Business segments 105 Exhibit 50: Bilcare Ltd. - Key offerings 106 Exhibit 51: Bilcare Ltd. - Key customers 106 Exhibit 52: Caligor Coghlan Pharma Services - Vendor overview 107 Exhibit 53: Caligor Coghlan Pharma Services - Business segments 107 Exhibit 54: Caligor Coghlan Pharma Services - Organizational developments 108 Exhibit 55: Caligor Coghlan Pharma Services - Key offerings 108 Exhibit 56: Caligor Coghlan Pharma Services - Key customers 109 Exhibit 57: Corden Pharma International GmbH - Vendor overview 110 Exhibit 58: Corden Pharma International GmbH - Business segments 110 Exhibit 59: Corden Pharma International GmbH - Organizational developments 111 Exhibit 60: Corden Pharma International GmbH - Key offerings 111 Exhibit 61: Corden Pharma International GmbH - Key customers 112 Exhibit 62: Mawdsley-Brooks & Co. Ltd. - Vendor overview 113 Exhibit 63: Mawdsley-Brooks & Co. Ltd. - Business segments 114 Exhibit 64: Mawdsley-Brooks & Co. Ltd. - Organizational developments 115 Exhibit 65: Mawdsley-Brooks & Co. Ltd. - Key offerings 115 Exhibit 66: Mawdsley-Brooks & Co. Ltd. - Key customers 116 Exhibit 67: PCI Pharma Services - Vendor overview 117 Exhibit 68: PCI Pharma Services - Business segments 117 Exhibit 69: PCI Pharma Services - Organizational developments 118 Exhibit 70: PCI Pharma Services - Key offerings 119 Exhibit 71: PCI Pharma Services - Key customers 119 Exhibit 72: Piramal Enterprises Ltd. - Vendor overview 120 Exhibit 73: Piramal Enterprises Ltd. - Business segments 120 Exhibit 74: Piramal Enterprises Ltd. - Organizational developments 121 Exhibit 75: Piramal Enterprises Ltd. - Segment focus 122 Exhibit 76: Piramal Enterprises Ltd. - Key offerings 122 Exhibit 77: Piramal Enterprises Ltd. - Key customers 122 Exhibit 78: Sentry BioPharma Services - Vendor overview 123 Exhibit 79: Sentry BioPharma Services - Business segments 124 Exhibit 80: Sentry BioPharma Services - Key offerings 124 Exhibit 81: Sentry BioPharma Services - Key customers 125 Exhibit 82: Sharp - Vendor overview 126 Exhibit 83: Sharp - Business segments 127 Exhibit 84: Sharp - Organizational developments 127 Exhibit 85: Sharp - Geographic focus 128 Exhibit 86: Sharp - Key offerings 128 Exhibit 87: Sharp - Key customers 129 Exhibit 88: The WestRock group - Vendor overview 130 Exhibit 89: The WestRock group - Business segments 130 Exhibit 90: The WestRock group - Organizational developments 131 Exhibit 91: The WestRock group - Segment focus 131 Exhibit 92: The WestRock group - Key offerings 132 Exhibit 93: The WestRock group - Key customers 132 Exhibit 94: Thermo Fisher Scientific Inc. - Vendor overview 133 Exhibit 95: Thermo Fisher Scientific Inc. - Business segments 134 Exhibit 96: Thermo Fisher Scientific Inc. - Organizational developments 135 Exhibit 97: Thermo Fisher Scientific Inc. - Geographic focus 137 Exhibit 98: Thermo Fisher Scientific Inc. - Segment focus 137 Exhibit 99: Thermo Fisher Scientific Inc. - Key offerings 138 Exhibit 100: Thermo Fisher Scientific Inc. - Key customers 138 Exhibit 101: Validation techniques employed for market sizing 141 Exhibit 102: Definition of market positioning of vendors 145

Arizona Lottery Florida Lottery International Game Technology Plc INTRALOT SA New York State Gaming Commission PA Lottery Pollard Banknote Ltd. Scientific Games Corp.  Texas Lottery Commission The California State Lottery